BSE Sensex 30 Stocks Regulatory Filings — October 14, 2026
The 14 October 2026 BSE SENSEX 30 digest is dominated by Reliance Industries' procedural milestones for its subsidiary Jio Platforms' IPO, which carries the highest materiality (8/10) and sets a clear calendar: anchor bidding on 19 October and subscription from 21 to 23 October at a ₹1,065–₹1,119 price band. The filings contain little period-over-period financial data, so portfolio-level trend analysis is limited; the one quantified performance read is TCS's Q2FY27, where revenue rose 0.5% QoQ and 2.8% YoY in constant currency, operating margin held at 24% and net margin at 19%, and AI revenue crossed $3.1 billion (over 10% of revenue). That result is mixed, as sequential declines in Consumer Business (-0.7% QoQ) and ERU (-0.5% QoQ) and a India project deferral offset the stability. Governance and regulatory items are low-impact: Sun Pharma's trading window is closed until 1 November ahead of its 30 October results, Bharti Airtel faces a ₹1.5 lakh DoT penalty it will not contest, and Axis Bank's ESOP allotment is a routine capital update. Overall, near-term investor attention centres on the Jio IPO pricing and the Sun Pharma and TCS results, not on any broad deterioration in the index constituents' disclosures.